198 related articles for article (PubMed ID: 16782906)
1. Anaplastic oligodendroglial tumors: a tale of two trials.
Gilbert MR; Lang FF
J Clin Oncol; 2006 Jun; 24(18):2689-90. PubMed ID: 16782906
[No Abstract] [Full Text] [Related]
2. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
Stege EM; Kros JM; de Bruin HG; Enting RH; van Heuvel I; Looijenga LH; van der Rijt CD; Smitt PA; van den Bent MJ
Cancer; 2005 Feb; 103(4):802-9. PubMed ID: 15637687
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial.
van den Bent MJ; Carpentier AF; Brandes AA; Sanson M; Taphoorn MJ; Bernsen HJ; Frenay M; Tijssen CC; Grisold W; Sipos L; Haaxma-Reiche H; Kros JM; van Kouwenhoven MC; Vecht CJ; Allgeier A; Lacombe D; Gorlia T
J Clin Oncol; 2006 Jun; 24(18):2715-22. PubMed ID: 16782911
[TBL] [Abstract][Full Text] [Related]
4. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.
; Cairncross G; Berkey B; Shaw E; Jenkins R; Scheithauer B; Brachman D; Buckner J; Fink K; Souhami L; Laperierre N; Mehta M; Curran W
J Clin Oncol; 2006 Jun; 24(18):2707-14. PubMed ID: 16782910
[TBL] [Abstract][Full Text] [Related]
5. [The molecular genetics of oligodendroglioma].
Teng LH; Gui QP; Xuan Q; Lu DH
Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):471-3. PubMed ID: 15498225
[No Abstract] [Full Text] [Related]
6. Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951.
Mokhtari K; Ducray F; Kros JM; Gorlia T; Idbaih A; Taphoorn M; Wesseling P; Hoang-Xuan K; Van den Bent M; Sanson M
Cancer; 2011 Jul; 117(13):3014-26. PubMed ID: 21246521
[TBL] [Abstract][Full Text] [Related]
7. Successful chemotherapy for newly diagnosed aggressive oligodendroglioma.
Macdonald DR; Gaspar LE; Cairncross JG
Ann Neurol; 1990 May; 27(5):573-4. PubMed ID: 2360797
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic oligodendroglioma and oligoastrocytoma.
van den Bent MJ
Neurol Clin; 2007 Nov; 25(4):1089-109, ix-x. PubMed ID: 17964027
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy and radiotherapy combination extends survival for patients with oligodendroglial tumors.
Printz C
Cancer; 2012 Sep; 118(18):4368. PubMed ID: 22952029
[No Abstract] [Full Text] [Related]
10. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.
van den Bent MJ; Brandes AA; Taphoorn MJ; Kros JM; Kouwenhoven MC; Delattre JY; Bernsen HJ; Frenay M; Tijssen CC; Grisold W; Sipos L; Enting RH; French PJ; Dinjens WN; Vecht CJ; Allgeier A; Lacombe D; Gorlia T; Hoang-Xuan K
J Clin Oncol; 2013 Jan; 31(3):344-50. PubMed ID: 23071237
[TBL] [Abstract][Full Text] [Related]
11. Intensified PCV-chemotherapy with optional stem cell support in recurrent malignant oligodendroglioma.
Zander T; Nettekoven W; Kraus JA; Pels H; Ko YD; Vetter H; Klockgether T; Schlegel U
J Neurol; 2002 Aug; 249(8):1055-7. PubMed ID: 12195453
[TBL] [Abstract][Full Text] [Related]
12. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of oligodendroglial tumours: current developments.
van den Bent MJ
Forum (Genova); 2000; 10(2):108-18. PubMed ID: 10875973
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.
Buckner JC; Gesme D; O'Fallon JR; Hammack JE; Stafford S; Brown PD; Hawkins R; Scheithauer BW; Erickson BJ; Levitt R; Shaw EG; Jenkins R
J Clin Oncol; 2003 Jan; 21(2):251-5. PubMed ID: 12525516
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy plus temozolomide or PCV in patients with anaplastic oligodendroglioma 1p19q codeleted.
Gonzalez-Aguilar A; Reyes-Moreno I; Peiro-Osuna RP; Hernandez-Hernandez A; Gutierrez-Aceves A; Santos-Zambrano J; Guerrero-Juarez V; Lopez-Martinez M; Castro-Martinez E
Rev Neurol; 2018 Oct; 67(8):293-297. PubMed ID: 30289152
[TBL] [Abstract][Full Text] [Related]
16. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
Levin VA
Oncology (Williston Park); 2015 Apr; 29(4):264, 266-8. PubMed ID: 25952490
[No Abstract] [Full Text] [Related]
17. Efficacy and feasibility of procarbazine, ranimustine and vincristine chemotherapy, and the role of surgical resection in anaplastic oligodendroglioma.
Yamamoto M; Iwaasa M; Nonaka M; Tsugu H; Nabeshima K; Fukushima T
Anticancer Res; 2005; 25(6A):3715-23. PubMed ID: 16302731
[TBL] [Abstract][Full Text] [Related]
18. Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors.
Lassman AB; Hoang-Xuan K; Polley MC; Brandes AA; Cairncross JG; Kros JM; Ashby LS; Taphoorn MJB; Souhami L; Dinjens WNM; Laack NN; Kouwenhoven MCM; Fink KL; French PJ; Macdonald DR; Lacombe D; Won M; Gorlia T; Mehta MP; van den Bent MJ
J Clin Oncol; 2022 Aug; 40(23):2539-2545. PubMed ID: 35731991
[No Abstract] [Full Text] [Related]
19. Chemotherapy for oligodendroglioma. Progress report.
Cairncross JG; Macdonald DR
Arch Neurol; 1991 Feb; 48(2):225-7. PubMed ID: 1993014
[No Abstract] [Full Text] [Related]
20. Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial.
Taphoorn MJ; van den Bent MJ; Mauer ME; Coens C; Delattre JY; Brandes AA; Sillevis Smitt PA; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; Allgeier A; Bottomley A;
J Clin Oncol; 2007 Dec; 25(36):5723-30. PubMed ID: 18089866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
